Endonovo Therapeutics
Woodland Hills
About Endonovo Therapeutics
Endonovo Therapeutics is a biotechnology company developing off-the-shelf regenerative products that no longer require the injection of stem cells. Its platform, Cell Free Therapeutics, harnesses the biological secretions of cells to create therapies that can be immediately administered following injuries or to treat acute and chronic diseases. Its second platform is the development of non-invasive, bioelectronics to stimulate the body's natural repair system to treat injuries and inflammatory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $15.5M
- Funding stage: IPO
- Last round: Post-IPO Debt (Nov 2016)
- Ticker: otcqb:ENDV
- Website: endonovo.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/endonovo-therapeutics-2242451 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.